Pricing strategies rarely fail because of one decision. More often, price potential is gradually ero...
Read moreGermany’s SHI reform bill removes some of the most significant AMNOG restrictions introduced in 20...
Read morePrice ambition is only defensible when the evidence can carry it Manufacturers can no longer r...
Read morePricing strategy is often treated as a launch activity. However, by the time teams begin detailed pr...
Read moreGermany’s draft GKV Contribution Rate Stabilisation Act signals a clearly tighter environment ...
Read moreOur previous article explored how TrumpRx might influence drug pricing in the US, the potential ...
Read moreTrumpRx, the most recent direct-to-consumer platform aimed at cutting drug prices for Amer...
Read moreIn 2026, U.S. policy shifts will link domestic US prices to internatio...
Read moreNegotiations between the Trump administration and pharmaceutical companies on lowering U.S...
Read moreAdvanced Therapy Medicinal Products (ATMPs) are offering transformative, and often life-saving, trea...
Read more